...
首页> 外文期刊>ACS medicinal chemistry letters >Synthesis and Structure-Activity Relationship Study of 1-Phenyl-1-(quinazolin-4-yl)ethanols as Anticancer Agents
【24h】

Synthesis and Structure-Activity Relationship Study of 1-Phenyl-1-(quinazolin-4-yl)ethanols as Anticancer Agents

机译:1-苯基-1-(喹唑啉-4-基)乙醇作为抗癌剂的合成及构效关系研究

获取原文
获取原文并翻译 | 示例
           

摘要

A quinazoline derivative PVHD121 (1a) was shown to have strong antiproliferative activity against various tumor-derived cell lines, including A549 (lung), NCI-H460 (lung), HCT116 (colon), MCF7 (breast), PC3 (prostate), and HeLa (cervical) cells with IC50 values from 0.1 to 0.3 mu M. A structure activity relationship (SAR) study at the 2- and 4-position of the quinazoline core lead to the discovery of more potent anticancer agents (14, 16, 17, 19, 24, and 31). The results of an in vitro tubulin polymerization assay and fluorescent based colchicine site competition assay with purified tubulin indicated that la inhibits tubulin polymerization by binding to the colchicine site.
机译:喹唑啉衍生物PVHD121(1a)对多种肿瘤来源的细胞系具有强大的抗增殖活性,这些细胞系包括A549(肺),NCI-H460(肺),HCT116(结肠),MCF7(乳腺),PC3(前列腺),和HeLa(宫颈)细胞,IC50值为0.1至0.3μM。对喹唑啉核心2位和4位的结构活性关系(SAR)研究导致发现了更有效的抗癌剂(14、16, 17、19、24和31)。体外微管蛋白聚合测定和用纯化的微管蛋白的基于荧光的秋水仙碱位点竞争测定的结果表明1a通过结合秋水仙碱位点抑制微管蛋白聚合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号